Osaic Holdings’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Osaic Holdings’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,424	Closed	-$15K	–	7652
2022 Q4	$15K	Sell	2,424 -1,801	-43%	-$9.97K	﹤0.01%	5755
2022 Q3	$22K	Sell	4,225 -721	-15%	-$4.53K	﹤0.01%	5533
2022 Q2	$31K	Buy	4,946 +619	+14%	+$2.08K	﹤0.01%	5328
2022 Q1	$15K	Buy	4,327 +3,278	+312%	+$12.1K	﹤0.01%	5907
2021 Q4	$5K	Buy	1,049 +21	+2%	+$127	﹤0.01%	6692
2021 Q3	$8K	Buy	1,028 +290	+39%	+$1.99K	﹤0.01%	6358
2021 Q2	$6K	Buy	738 +321	+77%	+$2.74K	﹤0.01%	6327
2021 Q1	$5K	Buy	417 +163	+64%	+$1.58K	﹤0.01%	6206
2020 Q4	$3K	Sell	254 -107	-30%	-$701	﹤0.01%	6011
2020 Q3	$2K	Buy	+361	New	+$2.16K	﹤0.01%	5928

Osaic Holdings's FSTX Position: Q1 2023 in Review

Osaic Holdings sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 2,424 shares — an estimated $15K sold.

Osaic Holdings first reported a position in FSTX in Q3 2020 and held it in 10 quarters. The position peaked at $31K in Q2 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Osaic Holdings reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Osaic Holdings sold 2,424 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $15K.
Osaic Holdings first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
Osaic Holdings's F-star Therapeutics, Inc. Common Stock position peaked at $31K in Q2 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.